SBIR/STTR Research Award

Probes and cell arrays for detection of bacterial toxins

Award identifier 242573851815a5f55c2ad425e17bf6c70d0705eb5efda824c80ab442f27bf9eaAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$196,552

Program and phase

SBIR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ALPHA UNIVERSE LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Z4JZCMG8Y6E9
Solicitation number
PHS2006-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Microarray technology offers an opportunity for simultaneous monitoring of the behavior of multiple markers within a mammalian cell and ultimately could be used for detection and elucidation of mechanisms of action of different biologically active agents, including those that are considered a threat in the biodefense area. The "predictive power" of probes used in diagnostic arrays and the cost of their application will be crucial parameters for introduction of array technology into routine diagnostic practices. We propose to develop an innovative robust system that will allow for the identification and isolation of the specific human DNA sequences that are up or down regulated in response to interaction between a eukaryotic cell with specific biologically active agents or groups of biologically active agents. Such sequences could be used as the basis for the construction of a cell array based detection system. In Phase I, we will demonstrate the technical feasibility of all fundamental aspects of the application for elaboration during subsequent phases. Our approach will be to use a flow cytometer cell sorting process to identify and isolate genetic elements, previously fused with the reporter sequences, which respond to the specific toxic agent challenge. In Phase II, our principal effort will be to extend our library of responsive elements that will be used for detection of major toxic agents and construct a prototype of the diagnostic cell array. The ultimate goal of this research will be to provide a general and robust approach for the detection of biologically active agents, especially when these agents have been engineered to elude immunoassays which are currently available. Cell arrays offer a new opportunity for sensitive and precise monitoring of biologically active substances. The goal of this application is to develop a system for identification of regulatory elements that will allow a substantial extension of discriminative abilities of cell arrays and creation of cell arrays capable of detection and identification of potential biowarfare agents.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

12 SBIR/STTR records share this UEI (2004–2014). Reported award amounts total $2,956,269. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.